Atopic Dermatitis in America

The National Eczema Association partnered with the Asthma and Allergy Foundation of America to study adults with atopic dermatitis (AD) in America, with support from Sanofi Genzyme and Regeneron. The purpose of the study was to:

  • Establish the prevalence of AD in the U.S. adult population
  • Determine the distribution of AD disease severity in adults
  • Understand the burden of disease for adults with AD

Learn more about the study HERE, or download the report HERE.

Get the latest eczema news delivered to your inbox.